Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Osteodystrophy in the millennium.

E Ritz1, M Schömig, J Bommer

  • 1Department of Internal Medicine, Ruperto Carola University, Heidelberg, Germany.

Kidney International. Supplement
|January 14, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

De novo glomerulonephritis in patients during remission from Wegener's granulomatosis.

Clinical nephrology·1992
Same author

Reduced capillary density in the myocardium of uremic rats--a stereological study.

Kidney international·1992
Same author

Renal histology in polycystic kidney disease with incipient and advanced renal failure.

Kidney international·1992
Same author

The effect of uninephrectomy on progression of renal failure in autosomal dominant polycystic kidney disease.

Journal of the American Society of Nephrology : JASN·1992
Same author

Severe hemorrhagic complications from infection with nephropathia epidemica strain of Hantavirus.

Clinical nephrology·1992
Same author

Disturbed calcium metabolism in renal failure--pathogenesis and therapeutic strategies.

Kidney international. Supplement·1992
Same journal

Effect of kidney disease on glucose handling (including genetic defects).

Kidney international. Supplement·2011
Same journal

Need for better diabetes treatment for improved renal outcome.

Kidney international. Supplement·2011
Same journal

Glucose dynamics and mechanistic implications of SGLT2 inhibitors in animals and humans.

Kidney international. Supplement·2011
Same journal

SGLT2 inhibitors: molecular design and potential differences in effect.

Kidney international. Supplement·2011
Same journal

Glucose handling by the kidney.

Kidney international. Supplement·2011
Same journal

Bone: from a reservoir of minerals to a regulator of energy metabolism.

Kidney international. Supplement·2011
See all related articles

Managing calcium phosphate metabolism in renal failure remains challenging. Future treatments like calcimimetics and improved phosphate binders offer hope for better control of hyperparathyroidism and bone disease.

Area of Science:

  • Nephrology
  • Endocrinology
  • Mineral and Bone Disorders

Background:

  • Renal failure causes complex calcium-phosphate metabolism derangements.
  • Current treatments for renal failure have limitations in controlling hyperphosphatemia, secondary hyperparathyroidism, and bone disease.

Purpose of the Study:

  • To review unresolved issues in calcium-phosphate metabolism in renal failure.
  • To discuss potential future therapeutic strategies and research directions.

Main Methods:

  • Literature review of research on renal failure and mineral metabolism.
  • Analysis of current treatment efficacy and limitations.
  • Anticipation of future therapeutic advancements and mechanistic insights.

Main Results:

Related Experiment Videos

  • Poor control of hyperphosphatemia persists.
  • Active vitamin D shows limited efficacy in preventing parathyroid hyperplasia.
  • Bone disease remains a challenge despite current management.

Conclusions:

  • Calcimimetics may offer a valuable approach to suppress or prevent hyperparathyroidism.
  • Development of more effective phosphate binders and understanding of parathyroid cell growth are anticipated.
  • Further research into osteoclast/osteoblast differentiation and coupling is crucial for improved patient management.